Detrex Corp. (DTRX: OTCQX U.S. Premier) | Detrex

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Detrex Corp. (DTRX: OTCQX U.S. Premier) | Detrex Corporation Reports Earnings for the Second Quarter of 2014 and Announces a Third Quarter Dividend

Detrex Corporation (OTCQX:DTRX), today announced 2014 second quarter net income from continuing operations of $521,140, or $0.30 per fully diluted share, compared to net income of $914,499 or $0.52 per fully diluted share, in the second quarter of 2013. Year-to-date 2014 net income from continuing operations was $1,063,085, or $0.61 per fully diluted share. This compares to 2013 year-to-date net income of $1,953,152, or $1.13 per fully diluted share. In the second quarter of 2014 the Company settled a dispute with the buyer of the Harvel Plastics, Inc. business in order to collect the escrow related to the transaction. The net income charge for the settlement and associated legal costs was $304,139. This amount is reflected in discontinued operations and second quarter net income after discontinued operations is $217,001, or $0.12 per fully diluted share, and on a year-to-date basis is $758,946, or $0.43 per fully diluted share. The Company also announced that it will pay a $0.25 quarterly dividend on September 17, 2014 to shareholders of record as of September 3, 2014.

Second quarter 2014 revenues of $9.7 million represent a continuation of activity levels during the first quarter of the year and represents a 13.3% year-over-year revenue reduction. On a year-to-date basis, 2014 sales were $19.9 million compared to $22.4 million for the year-to-date period in 2013. This represents a 11.1% year-over-year reduction. The reduction in revenue for both the quarter and year-to-date was largely the result of reduced sales of a product line that tends to fluctuate in volume from month to month and remained below prior year levels for the first six months. Sales to new and existing customers have partially offset this reduction in sales.

Earnings declined in the second quarter and year-to-date compared to 2013 due to reduced sales and unfavorable sales product mix. In addition the Company continued the program to strengthen Elco’s capabilities in sales, distribution, product development as well as infrastructure. Partially offsetting these investment costs are reduced expenses at the corporate level where measures have been taken to reduce executive and board compensation as well as other discretionary items. As part of these measures, Tom Mark assumed the role of Chairman at the April Board meeting. While the claim settlement for the Harvel transaction resulted in a charge to income, it facilitated the collection of the Harvel sale escrow in the second quarter of $2.1 million. The cash was used to pay down bank debt.

President and CEO, Tom Mark said, “Market conditions were sluggish in the first part of the second quarter but improved in June. July sales have shown continued improvement. We are continuing to invest in Elco while taking measures to offset a portion of the costs with reductions in corporate expense and finalizing legacy items. We continue to be focused on strategic opportunities to generate shareholder value and we look forward to keeping you informed of our progress.”

About Detrex Corporation

Founded in 1925, Detrex Corporation through its subsidiary The Elco Corporation is a leading manufacturer of high performance specialty chemicals including additives for industrial petroleum products and high purity hydrochloric acid.

Forward Looking Statements

Statements included in this press release that are not historical in nature are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 (the “1995 Act”). The words “believe,” “expect,” “anticipate,” “estimate,” “guidance,” “target” and similar expressions identify forward-looking statements. The Company cautions readers that forward-looking statements are subject to certain risks and uncertainties, which could cause actual results to differ materially from those projected in the forward-looking statements. Certain risks and uncertainties are identified from time to time in the Company’s reports. Some factors that could cause results to differ materially from those projected in the forward-looking statements include: market conditions, environmental remediation costs, pension expense and funding requirements, liquidation value of assets, and marketability of real estate and the market value and future liquidity of Detrex stock. The Company claims the protection of the safe harbor for forward-looking statements contained in the 1995 Act.

 
Detrex Corporation and Subsidiaries
Condensed Consolidated Statement of Operations
(unaudited, in thousands)
             
Three Months Ended Year to date
June 30 June 30

2014

2013

2014

2013

 
Net sales $ 9,732 $ 11,224 $ 19,918 $ 22,391
 
Cost of sales 6,825 7,335 13,766 14,737
Selling, general and administrative expense 1,715 2,214 3,734 4,035
Provision for depreciation and amortization 337 299 676 599
Provision for corporate environmental reserves - - - -
Interest Expense 54 18 109 17
Other (Income) Expense, net   11     22   22     44
Income from continuing operations
before income taxes 790 1,336 1,611 2,959
 
Provision for income taxes   269     422   548     1,006
Net Income from continuing operations 521 914 1,063 1,953
 
Discontinued operations:
Settlement (loss) on sale of Subsidiary, net of tax (304 ) 0 (304 ) 0
       
Net income $ 217   $ 914 $ 759   $ 1,953
 
Basic earnings (loss) per common share:
From continuing operations $ 0.31 $ 0.55 $ 0.63 $ 1.17
From discontinued operations   (0.18 )   -   (0.18 )   -
Net earnings per share $ 0.13   $ 0.55 $ 0.45   $ 1.17
 
Fully diluted earnings (loss) per common share:
From continuing operations $ 0.30 $ 0.53 $ 0.61 $ 1.13
From discontinued operations   (0.18 )   -   (0.18 )   -
Net earnings per share $ 0.12   $ 0.53 $ 0.43   $ 1.13
 
Shares outstanding,basic 1,676 1,676 1,676 1,676
Shares outstanding,fully diluted 1,730 1,723 1,730 1,723
 
Condensed Consolidated Balance Sheets
(unaudited - in thousands)
         
June 30 Dec 31

2014

2013

Assets
 
Current Assets $ 14,902 $ 16,777
 
Property and equipment, net 9,589 10,009
 
Other Assets 3,480 3,377
   
Total assets $ 27,971 $ 30,163
 
Liabilities and stockholders' equity
 
Current liabilities $ 7,478 $ 8,202
 
Non-current liabilities 6,221 7,610
 
Stockholders' equity 14,272 14,351
   
Total liabilities and stockholders' equity $ 27,971 $ 30,163
 

Scroll down for more posts ▼

Top 10 Most Recent News Articles

IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 2

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 3

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 4

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 6

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 1

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 6

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 3

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 3

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading

Top 5 Most Recently Viewed Articles

Revolutionizing the Game: NEWTON GOLF's Gravity Putter Launch

Updated Category News Views 260

Revolutionizing the Game with Gravity Putters Gravity, the putter division of NEWTON GOLF, has just launched an exciting new lineup of five premium putters as part of their latest series. This release marks an important milestone following the company’s rebranding efforts, highlighting their commitment to innovation in the golfing world. Overview of the New Gravity...

Continue Reading
Hikvision's 2024 Financial Success and Future Innovations

Updated Category News Views 644

Hikvision's Impressive Financial Results for 2024 Hikvision has proudly announced its financial results for the latest fiscal year, showcasing remarkable achievements. In 2024, the company generated total revenue of RMB 92.496 billion, reflecting a steady year-over-year growth rate of 3.53%. The company's first-quarter revenue for 2025 also demonstrated strength,...

Continue Reading
Verkada Enhances Security Solutions with SimonsVoss Partnership

Updated Category News Views 204

Verkada Enhances Security Solutions with SimonsVoss Partnership Verkada, a leader in cloud-based physical security, has unveiled a new integration with SimonsVoss wireless locks during the VerkadaOne London conference in front of over 400 IT and security professionals. This partnership marks a significant step forward for Verkada as they aim to improve access control...

Continue Reading
NVIDIA’s European AI Initiative: Innovation and Sovereignty

Updated Category News Views 514

NVIDIA’s European AI Initiative: Innovation and Sovereignty NVIDIA is embarking on a transformative journey across Europe, collaborating with various nations and technology leaders to establish groundbreaking AI infrastructure. This initiative focuses on solidifying digital sovereignty, boosting economic growth, and positioning Europe at the forefront of the global AI...

Continue Reading
Zevra Therapeutics Expands Workforce with New Inducement Grants

Updated Category News Views 72

Zevra Therapeutics Expands Workforce with New Inducement Grants CELEBRATION, Fla. — Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) is making strides to enhance its workforce by granting options to purchase a total of 53,000 shares of the company’s common stock. This initiative is part of the 2023 Employment Inducement Award Plan aimed at attracting new talent, particularly...

Continue Reading